未登录

A

Ana Micov

University of Belgrade

H指数:17

被引数:683

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stability and Efficacy of Mucoadhesive Eye Drops Containing Olopatadine HCl: Physicochemical, Functional, and Preclinical In Vivo Assessment

含奥洛他定盐酸盐的黏附性眼药水的稳定性和有效性：物理化学、功能和临床前体内评估

IF5.5

2025-04-150

OA

Metformin reduces inflammatory nociception in mice through a serotonin-dependent mechanism

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2025-03-010

PRE

Vortioxetine reduces the development of pain-related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down-regulation

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2024-09-191

OAAI

Synergism of polysaccharide polymers in antihistamine eye drops: Influence on physicochemical properties and in vivo efficacy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-04-012

PRE

The antidepressant drugs vortioxetine and duloxetine differentially and sex-dependently affect animal well-being, cognitive performance, cardiac redox status and histology in a model of osteoarthritis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-10-016

OAAI

Synergism between metformin and analgesics/vitamin B12 in a model of painful diabetic neuropathy

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-09-016

OAAI

Formulation of olopatadine hydrochloride viscous eye drops - physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2021-11-0115

PREAI

Infrared radiation from cage bedding moderates rat inflammatory and autoimmune responses in collagen-induced arthritis

SCIENTIFIC REPORTS

IF3.9

2021-02-034

OAAI

Vortioxetine reduces pain hypersensitivity and associated depression -like behavior in mice with oxaliplatin-induced neuropathy

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2020-12-0124

PREAI

Percutaneous delivery of levetiracetam as an alternative to topical nonsteroidal anti-inflammatory drugs: formulation development, in vitro and in vivo characterization

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2020-05-253

PRE

Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception

PSYCHOPHARMACOLOGY

IF3.3

2020-02-051

PREAI

Topical hydrogels with escin β-sitosterol phytosome and escin: Formulation development and in vivo assessment of antihyperalgesic activity

DRUG DEVELOPMENT RESEARCH

IF4.2

2019-07-1216

PREAI

Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors

IF5.1

2018-12-0110

PREAI

Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence

PHARMACOLOGY & THERAPEUTICS

IF12.5

2018-12-0134

PREAI

Potentiation of the ibuprofen antihyperalgesic effect using inorganically functionalized diatomite

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2018-01-019

PREAI

Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model

PSYCHOPHARMACOLOGY

IF3.3

2017-03-228

PREAI

Formulation of hydrogel-thickened nonionic microemulsions with enhanced percutaneous delivery of ibuprofen assessed in vivo in rats

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2016-09-0129

PREAI

Design of Block Copolymer Costabilized Nonionic Microemulsions and Their In Vitro and In Vivo Assessment as Carriers for Sustained Regional Delivery of Ibuprofen via Topical Administration

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2015-08-0120

PREAI

Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy

PHARMACOLOGICAL RESEARCH

IF10.5

2015-07-0122

PREAI

Application of Artificial Neural Networks in Prediction of Diclofenac Sodium Release From Drug-Modified Zeolites Physical Mixtures and Antiedematous Activity Assessment

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2014-04-0115

PREAI